Search the Newsreel

Dentsply Sirona (XRAY): Southpoint reports 7M-share, 3.5% ownership in 13G/A

Southpoint Master Fund and its affiliates, including John S. Clark II, have reported a beneficial ownership of 7,000,000 shares, representing a 3.5% stake in Dentsply Sirona Inc. (XRAY). This disclosure was made in an amended Schedule 13G/A filing, indicating shared voting and dispositive power …

Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Investor Relations - Wade MoodyPresident and Chief Executive Officer - Daniel T. ScavillaExecutive Vice President and Chief Financial Officer - John C. Fortson TAKEAWAYS Revenue -- $898 million, …

Is DENTSPLY SIRONA’s (XRAY) Steady Buyback and Reaffirmed Outlook Reframing Its Risk‑Reward Profile?

DENTSPLY SIRONA (XRAY) reported Q2 2026 sales of US$898 million, returning to a net income of US$37 million, and reaffirmed its full-year 2026 sales guidance of US$3.5 billion to US$3.6 billion, despite lower year-on-year revenue. The company continued its share buyback program, repurchasing 1.3 …

DENTSPLY SIRONA (XRAY) gains AQR Capital as 5.22% beneficial owner

AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have reported a 5.22% beneficial ownership in DENTSPLY SIRONA Inc. (XRAY), amounting to 10,458,771 shares. This disclosure was made via a Schedule 13G SEC filing, indicating a passive investment with shared voting …

DS World Las Vegas 2026 connects clinical and laboratory education

Dentsply Sirona World Las Vegas 2026 will offer a comprehensive educational program for dental professionals, connecting clinical expertise, laboratory innovation, and digital workflows to advance patient care. The event, taking place from September 24 to 26, will feature main stage presentations by clinical experts …

The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call

Dentsply Sirona (XRAY) reported Q2 CY2026 earnings, exceeding analyst expectations for revenue and adjusted EPS, though shares declined post-announcement. Management attributed revenue decline to lower sales in key segments and regions, noting the company is in a "turnaround" phase with uneven improvements. Analysts focused …

DENTSPLY SIRONA (XRAY) CFO awarded 104,200 stock options and 24,014 RSUs

DENTSPLY SIRONA (XRAY) EVP & CFO John C. Fortson was granted 24,014 Restricted Stock Units (RSUs) and 104,200 stock options. The RSUs and stock options vest in one-third annual increments over a three-year period, ending August 10, 2029. The stock options have an exercise …

Pacer Advisors Inc. Has $266,000 Stake in DENTSPLY SIRONA Inc. $XRAY

Pacer Advisors Inc. significantly reduced its stake in DENTSPLY SIRONA Inc. by 90.5% in the first quarter, now holding 22,973 shares valued at $266,000. Institutional investors collectively own 95.7% of the company, while analyst ratings are mixed with an average "Hold" and target price …

DENTSPLY SIRONA (XRAY) SVP Frohning reports 802 tax-withheld shares

Andrea L. Frohning, SVP and CHRO of DENTSPLY SIRONA Inc. (XRAY), reported the disposition of 802 shares of common stock on August 7, 2026. These shares were withheld to cover taxes related to the vesting of her Restricted Stock Units and dividend equivalent units. …

XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds

XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q2 CY2026, but sales fell by 4.1% year on year to $898 million. On the other hand, the company's full-year revenue guidance …

Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today

Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today What Happened? Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) fell 6.8% in the afternoon session after the company reported second-quarter 2026 earnings, which featured a beat on profit estimates, was overshadowed by a weak …

DENTSPLY SIRONA Inc. (XRAY) Stock Forecasts

Morningstar has published an analyst report on DENTSPLY SIRONA Inc. (XRAY), stating that its weak recovery momentum remains unchanged due to soft volume impacting results. The report notes that Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies, formed …

Dentsply's Full Recovery Timeline Looks Uncertain as Tough Market and Competition Put Pressure

Dentsply Sirona, a major dental equipment manufacturer, faces an uncertain recovery due to intense market competition and soft sales volume. The company has invested in its Cerec system and expanded partnerships to adapt, but its competitive edge has been challenged by new entrants. Analysts …

Dentsply Sirona Earnings: Weak Recovery Momentum Unchanged as Soft Volume Weighs on Results

Dentsply Sirona reported a decline in revenue and adjusted EPS for the second quarter, although both figures surpassed FactSet consensus estimates. The company maintained its full-year revenue and EPS guidance, despite the share price dropping 3% after hours. The article highlights that weak recovery …

Dentsply Sirona (XRAY) Stock Drops As Revenue Weakens Despite Profit Rebound

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has an average "Hold" recommendation from analysts, with nine firms rating it Hold, three Sell, and three Buy. The company's Q2 earnings beat expectations with an adjusted EPS of $0.52 and revenue of $898 million, though revenue declined year-over-year. Analysts …

DENTSPLY SIRONA Inc. Stock 12‑Month Price Target Raised to $13.7, Implies 4% Upside

Analysts have raised DENTSPLY SIRONA Inc.'s average 12-month price target from $13.53 to $13.7, suggesting a 4% potential upside based on its closing price on August 6th. The consensus rating from 19 analysts remains "Hold," with a breakdown of 4 Buys, 13 Holds, and …

DENTSPLY SIRONA (XRAY) Could Be 11% Undervalued As Earnings Beat Meets Weak Returns

DENTSPLY SIRONA Inc (XRAY) Aktuelle Aktien-News

Dentsply Sirona Reports $898 Million in Net Sales for Second Quarter 2026

Dentsply Sirona reported net sales of $898 million for the second quarter of 2026, alongside an adjusted earnings per share of $0.52. Despite a 13.2% decline in its orthodontic and implant segment sales, the company maintained its full-year financial outlook, projecting net sales between …

DENTSPLY SIRONA Q2 Earnings Call Highlights

1% Undervalued? DENTSPLY SIRONA (XRAY) As Earnings Test Its Recovery Story

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Earnings trigger and recent business updates DENTSPLY SIRONA (XRAY) is in focus after reporting second quarter 2026 earnings on 6 August, alongside reaffirmed full year …

XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales

DENTSPLY SIRONA Inc. XRAY reported second-quarter 2026 adjusted earnings per share (EPS) of 52 cents, down 1.6% year over year on an actual-value basis. The bottom line beat the Zacks Consensus Estimate of 36 cents by 44.4%. GAAP EPS in the quarter was 18 …

Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings

Dentsply International (XRAY) reported $898 million in revenue for the quarter ended June 2026, representing a year-over-year decline of 4.1%. EPS of $0.52 for the same period compares to $0.52 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $883.85 …

DENTSPLY SIRONA Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:XRAY) 2026-08-06

DENTSPLY SIRONA (NASDAQ:XRAY) announced its quarterly earnings, reporting an adjusted EPS of $0.52, beating consensus estimates of $0.35, with revenue of $898 million, slightly above expectations. Despite this beat, revenue declined 4.1% year-over-year, and the company maintained its 2026 guidance, anticipating sequential declines in …

Dentsply Sirona maintains 2026 outlook of $3.5B-$3.6B sales and $1.40-$1.50 adjusted EPS while ramping return-to-growth investments

Earnings Call Insights: Dentsply Sirona (XRAY) Q2 2026 MANAGEMENT VIEW * Daniel Scavilla (President, CEO, Interim Principal Financial Officer & Director) highlighted a key leadership change: "I'd like to welcome John Fortson to his first earnings call as Executive Vice President and Chief Financial …

Dentsply Sirona Q2 2026 Earnings: Sales Decline as GAAP Margins Recover

Dentsply Sirona reported a Q2 2026 net sales decline of 4.1% to $898 million, though GAAP diluted EPS improved to $0.18 from a prior-year loss, largely due to the absence of impairment charges. While GAAP gross margins and operating cash flow increased significantly, constant-currency …

Dentsply Sirona Q2 2026: Umsatz sinkt, GAAP-Margen erholen sich

Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

DENTSPLY SIRONA ($XRAY) Releases Q2 2026 Earnings, Stock Rises

Dentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations

Dentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q2 CY2026 results topping the market's revenue expectations , but sales fell by 4.1% year on year to $898 million. On the other hand, the company's full-year revenue guidance …

DENTSPLY SIRONA (XRAY): First Eagle discloses 851,347-share position in 13G/A

First Eagle Investment Management, LLC has filed an amended Schedule 13G/A, disclosing a beneficial ownership of 851,347 shares in DENTSPLY SIRONA Inc. (XRAY). This position represents 0.4% of the company's common stock, keeping First Eagle below the 5% ownership threshold. The filing indicates First …

Earnings Flash (XRAY) DENTSPLY SIRONA Inc. Reports Q2 Revenue $898.0M, vs. FactSet Est of $889.9M

DENTSPLY SIRONA Inc. (XRAY) reported its Q2 revenue at $898.0 million, surpassing FactSet's estimate of $889.9 million. The company is a diversified manufacturer of professional dental products and technologies, offering comprehensive solutions across various dental segments. The report also highlights recent company news, including …